These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9037889)

  • 21. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contributions of the Japanese Pharmacopoeia to the Quality of Generic Pharmaceuticals].
    Izutsu KI
    Yakugaku Zasshi; 2020; 140(6):773-776. PubMed ID: 32475926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of animal usage: British Pharmacopoeia Commission policy.
    Rabouhans ML
    Dev Biol Stand; 1986; 64():11-6. PubMed ID: 3792640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report.
    World Health Organ Tech Rep Ser; 1992; 823():1-134. PubMed ID: 1462605
    [No Abstract]   [Full Text] [Related]  

  • 25. [Animal experiments in the context of quality control of pharmaceuticals. Review of the European Pharmacopoeia, 4th edition, 2002].
    Sponer G
    ALTEX; 2004; 21(2):73-80. PubMed ID: 15195228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 27. [Application of thermogravimetry to loss on drying test and water-content determination of drugs].
    Hui ZZ; Kitajima A; Tanimoto T; Okada S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):144-6. PubMed ID: 9641830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ICH4 and pharmacopoeias: similarities and differences].
    Artiges A
    Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiological tests on oral pediatric medicines--requirements for an improved pharmacopoeia monograph.
    Long PF; Han J; Tuleu C; Wong IC
    Ann Pharmacother; 2006 Jan; 40(1):158-9. PubMed ID: 16368921
    [No Abstract]   [Full Text] [Related]  

  • 31. Information chapters in pharmacopoeias.
    Banes D
    Ann Ist Super Sanita; 1975; 11(3-4):290-5. PubMed ID: 1234730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

  • 33. USP to cut back on salt in drug names.
    Thompson CA
    Am J Health Syst Pharm; 2013 Jan; 70(2):94. PubMed ID: 23292260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Exceptional Application of Content Uniformity Test and Weight Variation Test in the Japanese Pharmacopoeia 13 revision and usage of these tests for in-process tests].
    Katori N; Aoyagi N; Kojima S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):204-5. PubMed ID: 9641846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Computer-aided differential thermal analysis of drugs].
    Braun V; Wollmann H
    Pharmazie; 1990 Jul; 45(7):502-6. PubMed ID: 2236193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacopeia and preparations for cutaneous application].
    Esnault F; Etchegaray JP; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines and pharmacopoeial standards for pharmaceutical impurities: overview and critical assessment.
    Snodin DJ; McCrossen SD
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):298-312. PubMed ID: 22507740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R
    AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Third Policy Arena: Standard-Setting Organizations.
    Consult Pharm; 2016 Mar; 31(3):176. PubMed ID: 26975597
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a Logic Model for Promoting Incorporation of the Concepts of Impurity-Related ICH Guidelines into Pharmacopoeias Based on Cause and Effect Analysis.
    Matsuhama M; Saito R; Miyazaki S
    Chem Pharm Bull (Tokyo); 2020; 68(11):1034-1048. PubMed ID: 33132370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.